A major new United Nations assessment has renewed scrutiny of the chemicals woven into modern life. Some can imitate, block or otherwise interfere with hormones — the body’s finely tuned chemical messaging system. The evidence is serious, but it is not a licence for panic: the science is complex, the strength of evidence differs between chemicals and health outcomes, and exposure does not automatically mean harm.
- What is the endocrine system — and how can chemicals interfere with it?
- Why the timing of exposure matters
- The chemicals under scrutiny
- How widespread is everyday exposure?
- The problem with testing chemicals one at a time
- What does the human-health evidence actually show?
- Wildlife provides a warning from the real world
- Are regulators keeping up?
- What can consumers realistically do?
- The unanswered questions
- Sources and further reading
On 17 November 2026, the United Nations Environment Programme (UNEP) and the World Health Organization (WHO) published State of the Science on Endocrine-Disrupting Chemicals 2026, a 240-page assessment and the first major global update since 2012. It concludes that research has strengthened and broadened concern about effects on reproductive development, brain and neurological function, thyroid regulation, metabolism, immunity and cardiovascular health. It also highlights the importance of exposure during pregnancy and early development, and the difficulty of assessing the mixtures to which people and wildlife are actually exposed.
The report is not claiming that every plastic container, cosmetic or household product is dangerous. It raises a more difficult question: how well do we understand the combined, long-term effects of thousands of chemicals used across everyday products, and are testing and regulation keeping pace?
What is the endocrine system — and how can chemicals interfere with it?
The endocrine system is a network of glands and organs that release hormones into the bloodstream. Hormones act as signals, helping coordinate growth, puberty, reproduction, metabolism, stress responses, sleep, mood and the development of the brain and other organs. The pituitary, thyroid, adrenal glands, pancreas, ovaries and testes are among its key components. Their signals operate at very low concentrations and are regulated through feedback loops: when a hormone level rises or falls, the body adjusts production, release or sensitivity to keep processes within a workable range.

An endocrine-disrupting chemical (EDC) can interfere at several points. It may bind to a hormone receptor and imitate the natural signal; occupy a receptor and block the real hormone; alter the production, transport or breakdown of hormones; or interfere with the enzymes and feedback systems that regulate them. A substance does not have to resemble a hormone perfectly to affect a pathway. Some chemicals act on more than one receptor or biological process.
There is an important distinction here. A chemical that interacts with the endocrine system is not automatically an endocrine disruptor. The European Food Safety Authority (EFSA) explains that scientists distinguish an endocrine-active substance, which interacts with hormonal processes, from an endocrine disruptor, for which that interaction causes a harmful effect. The body can compensate for some disturbances. Establishing that a chemical causes harm therefore requires evidence of both endocrine activity and an adverse outcome, not simply proof that a molecule can bind to a receptor.
Why the timing of exposure matters
Hormones do more than maintain the adult body. During pregnancy, infancy, childhood and puberty they help organise the development of tissues and organs. The timing of a chemical exposure can therefore matter as much as its amount. A disturbance during a short developmental window may alter how a tissue forms or how its regulatory systems are set up. The consequences might not become apparent until years later, when fertility, metabolism or neurological function is assessed.
The 2026 UNEP–WHO assessment says endocrine-disrupting chemicals have been detected in blood, breast milk and umbilical cord blood, demonstrating that exposure can occur before birth and during early life. Detection is evidence of exposure, not by itself proof that a particular individual will suffer an illness. The risk depends on the chemical, dose, duration, route of exposure, developmental stage and the person’s wider circumstances.
This is one reason scientists study pregnancy and childhood cohorts over many years. Researchers may measure chemicals or their breakdown products in urine, blood or other samples, then compare those measurements with developmental, hormonal or health outcomes. Such studies can identify patterns in real populations, but they face difficult questions: people encounter several chemicals at once; exposure can change over time; and factors such as diet, income, occupation, smoking and other environmental conditions can influence both exposure and health.
The chemicals under scrutiny
Endocrine-disrupting chemicals are not one chemical family. They include substances with very different structures, uses, persistence and biological effects. Some are legacy pollutants that remain in the environment long after their original uses were restricted. Others are still used in materials and products.
Bisphenols
Bisphenol A (BPA) has been used in polycarbonate plastics and epoxy resins, including some food-contact materials. It has attracted attention because it can interact with oestrogen-related signalling and other biological pathways. Restrictions and product reformulations have led to the marketing of alternatives such as bisphenol S (BPS) and bisphenol F (BPF). But replacing one chemical with a close relative does not automatically establish that the substitute is safer. Each alternative needs to be assessed on its own evidence, including whether it has similar biological activity and how much people are exposed to it.
Phthalates
Phthalates are a group of chemicals used for different purposes, notably to make some plastics more flexible. Depending on the compound, they may be present in certain flooring, cables, packaging, medical products, cosmetics and fragranced products. Some phthalates or their metabolites have been studied for effects on steroid hormone signalling and reproductive development. It is misleading, however, to treat every phthalate as interchangeable: the compounds differ, and regulatory decisions often apply to specific substances or defined groups.
PFAS and persistent pollutants
Per- and polyfluoroalkyl substances (PFAS) are a large group of chemicals valued for properties such as resistance to heat, water and oil. They have been used in applications including some non-stick coatings, stain-resistant treatments, firefighting foams and industrial processes. Certain PFAS persist for long periods and have been associated in research with several health outcomes, including changes in lipid metabolism and immune response. PFAS are not all identical, and the term covers a very broad chemical universe; conclusions about one compound should not casually be applied to the entire group.
Polychlorinated biphenyls (PCBs), dioxins and some older pesticides are different examples of persistent pollutants. Many have been restricted or banned, but their persistence and ability to accumulate in food webs mean that historical contamination can remain relevant. People may encounter them through contaminated soil, dust, water or food, while wildlife can be exposed through sediments and prey.
How widespread is everyday exposure?
Exposure can happen through food and drinking water, inhalation of indoor or outdoor air and dust, and absorption through the skin. Food packaging and processing materials are one possible route; household dust can contain chemicals released from furnishings, electronics and building materials; and some personal-care or cleaning products may contain substances of concern. Agricultural chemicals and industrial emissions can contribute to exposure beyond the home.
The route depends on the substance. Some chemicals are rapidly broken down and leave the body, so researchers measure short-lived metabolites and need repeated samples to estimate exposure. Others persist in the body or environment for much longer. A single test is therefore a snapshot, not necessarily a reliable record of a person’s exposure over months or years.
The UNEP–WHO report notes that more than 350,000 chemicals and chemical mixtures are registered for production and use globally, while only a small fraction have been evaluated for endocrine-disrupting properties. That figure should not be read as meaning that 350,000 substances are all in everyday consumer products or that all are harmful. It illustrates the scale and diversity of chemical production compared with the limited scope of endocrine-specific assessment.
The problem with testing chemicals one at a time
Real-world exposure is rarely a neat laboratory experiment involving one chemical. A person may encounter several bisphenols, phthalates, pesticides and persistent pollutants through different routes over the same period. Each individual exposure may be low, but the combined biological effect is not always captured by testing each substance in isolation.
Mixture science is challenging. Chemicals may act through the same pathway, through different pathways that converge on one outcome, or in ways that interact. Effects can be additive, less than additive or, in some circumstances, greater than would be expected from adding individual effects. The size and direction of an interaction depend on the chemicals, concentrations, timing and biological endpoint. It is not scientifically sound to assume that every mixture is automatically more toxic, but neither is it sufficient to assume that individual chemical assessments always describe combined exposure.
Hormone biology also complicates the familiar idea that a higher dose must always produce a proportionally larger effect. Hormone systems use receptors, feedback loops and finely balanced signals. Some experimental studies of endocrine-active substances have reported non-monotonic dose-response relationships, in which the shape of the response changes across the tested range. This is an established subject of scientific investigation, not a universal rule that every EDC causes harm at any tiny dose. The relevance of a particular low-dose finding to human health must be tested against exposure levels, biological plausibility and the full weight of evidence.
What does the human-health evidence actually show?
The new global assessment reports that evidence has strengthened for links between EDC exposure and fertility and reproductive development, brain development and neurological function, thyroid and other hormone regulation, metabolism, immunity and cardiovascular health. It also identifies emerging concerns, including possible effects involving metabolic liver disease and the kidneys. The report is a synthesis for policymakers, not a diagnosis of individual risk and not proof that every chemical in these broad groups causes every listed condition.
A 2025 umbrella review in Ecotoxicology and Environmental Safety examined 67 existing meta-analyses covering 109 health outcomes and more than 7,500 unique articles. It found statistically significant harmful associations for 69 outcomes. But the authors also reported that all 109 outcomes were derived from meta-analyses of observational studies, and that most of the evidence was graded as low or very low quality. This is a crucial qualification: a large body of associations can identify priorities for research and prevention, but it does not automatically establish that exposure caused the outcome.
Observational research is essential because deliberately exposing people to potentially harmful chemicals would be unethical. Yet it cannot always separate cause from correlation. Exposure may be measured imperfectly; studies may use different definitions; results may be affected by confounding factors; and publication bias can make positive findings more visible than null results. Stronger conclusions emerge when different kinds of evidence — human studies, animal research, mechanistic experiments and exposure data — point in the same direction.
A scoping review published online on 14 November 2026 mapped 797 human studies examining endocrine-disrupting chemicals and neurobehavioural outcomes. It found that research was concentrated on prenatal and early-life exposure, with cognition, psychomotor development and ADHD among the most frequently examined outcomes. The authors described a large but uneven and methodologically varied evidence base. A scoping review maps what has been studied; it does not calculate a single pooled risk or prove that a chemical causes a particular diagnosis.
Wildlife provides a warning from the real world
The effects of hormone-active pollution are not confined to laboratory animals or human health studies. One of the clearest environmental examples comes from fish living downstream of sewage-treatment discharges. Some male fish exposed to oestrogenic substances have developed female characteristics, including changes in reproductive tissues and the production of egg-yolk proteins normally associated with females.
UK research has documented widespread feminisation in wild roach populations and linked it to oestrogenic substances in wastewater. These include natural and synthetic oestrogens excreted by people, as well as other chemicals with oestrogen-like activity. The Environment Agency’s research programme compared contemporary observations with earlier surveys and investigated whether these effects persisted in English rivers. This example matters because it connects a known exposure pathway, a biological mechanism and measurable changes in wild animals.
It does not mean that every sewage discharge produces the same effect, or that feminised fish automatically demonstrate a population collapse. Ecological outcomes depend on species, exposure, habitat, reproduction and other pressures. But it shows how chemicals designed for one purpose — including medicines taken by people — can enter wastewater and affect organisms downstream. The 2026 UNEP–WHO assessment broadens this concern across fish, birds, amphibians and mammals, describing links with impaired reproduction, development and behaviour.
Are regulators keeping up?
Regulation has changed substantially since the first major UNEP–WHO assessment in 2002 and its 2012 update. Some substances have been banned or restricted, testing methods have improved, and regulators increasingly consider endocrine activity when evaluating chemicals. In Europe, EFSA’s framework distinguishes endocrine activity from an adverse endocrine-disrupting effect, while chemical legislation and sector-specific rules govern particular uses and substances.
But the new assessment identifies persistent gaps. The number of chemicals in commerce is large; endocrine-specific testing is incomplete; and regulators often assess substances individually even though exposure occurs as mixtures. There is also a substitution challenge: removing a chemical from a product is only a durable solution if the replacement is adequately assessed and does not simply transfer the problem to a less-studied relative.
UNEP’s companion synthesis, From Evidence to Action, points to opportunities across food packaging, cosmetics, toys, textiles, healthcare, agriculture, pharmaceuticals and waste management. The practical policy questions include improving transparency about product ingredients, prioritising chemicals with stronger evidence of harm, improving monitoring, assessing groups of related substances and encouraging safer alternatives. The challenge is to protect health without treating every chemical as equally dangerous or every association as settled science.
What can consumers realistically do?
Individual choices cannot substitute for effective chemical regulation, and it is neither realistic nor necessary to eliminate all contact with modern materials. Some modest steps may reduce particular exposures, although the benefit depends on the chemical and product involved. Avoid heating food in containers not intended for that purpose; follow manufacturers’ instructions for food-contact materials; reduce unnecessary dust by damp-dusting and cleaning; ventilate indoor spaces; and use products as directed rather than assuming that labels such as “natural”, “green” or “BPA-free” guarantee safety.
For products intended for babies and young children, it is reasonable to pay attention to applicable safety standards and recall notices. People with occupational exposure — for example, in certain manufacturing, agricultural, healthcare or waste-handling roles — may need workplace-specific controls and advice. Consumers should be wary of expensive “detox” products or tests marketed as a way to diagnose chemical poisoning: the presence of a chemical or metabolite does not, by itself, establish illness, and medical interpretation requires validated testing and clinical context.
The unanswered questions
The 2026 report is important not because it resolves every scientific dispute, but because it shows how much has changed since 2012 — and how much remains uncertain. Researchers still need better ways to measure exposure over time, understand mixtures, identify sensitive developmental windows, compare chemicals and substitutes, and translate population-level associations into meaningful estimates of risk. Some chemicals have substantial evidence behind them; others remain poorly studied.
The central issue is not whether modern life can be made entirely chemical-free. It cannot. The question is whether society can identify the substances that pose avoidable risks, test them before widespread use, monitor how people and ecosystems are exposed, and replace harmful chemicals with genuinely safer alternatives. The new UNEP–WHO assessment suggests that prevention and better oversight are justified even while important scientific questions remain open.
Sources and further reading
- UNEP and WHO — State of the Science on Endocrine-Disrupting Chemicals 2026 (technical assessment, 240 pages).
- UNEP — 17 November 2026 report announcement and findings.
- European Food Safety Authority — Endocrine disruptors: definitions and assessment.
- Chen et al. (2025), “Endocrine disrupting chemicals exposure and health: An umbrella review”, Ecotoxicology and Environmental Safety.
- Krishnamoorthy et al. (online 14 November 2026), “Exploring the Link between Exposure to Endocrine-Disrupting Chemicals and Neurobehavioral Outcomes in Humans: A Scoping Review”.
- Vandenberg et al. (2012), “Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses”, Endocrine Reviews.
- UK Environment Agency — Oestrogenic effects in wild fish: comparing contemporary and historical impacts.
- UNEP — Endocrine-disrupting chemicals: exposure pathways infographic.
Image credit: Endocrine System.svg by A.Spielhoff, Wikimedia Commons, CC BY 4.0. Attribution and licence details are provided in the image caption.
